Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_assertion type Assertion NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_head.
- NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_assertion description "[Patients with RA had elevated but variable surface expression of PAR(2) on CD14+ monocytes compared with control subjects (median (1st to 3rd quartiles) 1.76% (0.86-4.10%) vs 0.06% (0.03-0.81%), p<0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_provenance.
- NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_assertion evidence source_evidence_literature NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_provenance.
- NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_assertion SIO_000772 22294633 NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_provenance.
- NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_assertion wasDerivedFrom befree-2016 NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_provenance.
- NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_assertion wasGeneratedBy ECO_0000203 NP957622.RANE0J-YAZfAF_Tz0g0-UvC6SA1o3K8VBGnQEBb_9V_ng130_provenance.